Stem cells in mismatched placental blood can safely reconstitute hemopoiesis in children.
This is a preview of subscription content, log in via an institution to check access.
References
Broxmeyer, H.E. et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sri. USA 86, 3828–3832 (1989).
Gluckman, E. et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from a HLA-identical sibling. N. Engl. J. Med. 321, 1174–1178 (1989).
Kurtzberg, J. et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N. Engl. J. Med. 335, 157–166(1996).
Laporte, J. et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N. Engl. J. Med. 335, 167–170 (1996).
Appelbaum, F.R. et al. Allogeneic marrow transplantation for chronic myeloid leukemia. Med. Oncol. 11, 69–74 (1994).
Kohn, D.B. et al. Engraftment of gene-modified umbilical cord blood in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017–1023 (1995).
Butler, D. US company comes under fire over patent on umbilical cord cells. Nature 382, 99 (1996).
Gluckman, E., O'Reilly, R., Wagner, J. & Rubinstein, P. Patents versus transplants. Nature 382, 108 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brenner, M. Placental blood transplant: Who will benefit?. Nat Med 2, 969–970 (1996). https://doi.org/10.1038/nm0996-969
Issue Date:
DOI: https://doi.org/10.1038/nm0996-969
- Springer Nature America, Inc.